Stocks and Investing
Stocks and Investing
Fri, May 12, 2017
[ 08:45 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tim Lugo Downgraded (AKTX) to Hold on, May 12th, 2017
Tim Lugo of William Blair, Downgraded "Akari Therapeutics, Plc" (AKTX) to Hold on, May 12th, 2017.
Tim has made no other calls on AKTX in the last 4 months.
There is 1 other peer that has a rating on AKTX. Out of the 1 peers that are also analyzing AKTX, 0 agree with Tim's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tim
- Madhu Kumar of "Chardan Capital" Reiterated at Strong Sell with Increased Target to $130 on, Monday, April 17th, 2017
Contributing Sources